← Eichor
Study identifier: NCT06390930 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS

Condition: Multiple Sclerosis · Multiple Sclerosis, Relapsing-Remitting · Multiple Sclerosis, Secondary Progressive  ·  Sponsor: Shirley Ryan AbilityLab

PhaseNA
Planned participants22
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

This study seeks to explore changes in the neural pathways and arm function following a breathing intervention in the multiple sclerosis (MS) population. The breathing intervention, known as Acute Intermittent Hypoxia (AIH), involves breathing brief bouts of low levels of oxygen. Research has found AIH to be a safe and effective intervention resulting in increased ankle strength in people with MS. Here, the study examines arm and hand function before and after AIH. In order to better understand the brain and spinal cord response to AIH, the investigators will measure muscle response, and signals sent from the brain to the arm muscles before and after AIH.

This description comes directly from the study's public registry record.

Talk to the study team

Rachel Kalvakota, OTD, OTR/L  ·  3122383947  ·  rkalvakota@sralab.org

Always discuss trial participation with your own doctor first.

Locations (1)

Shirley Ryan AbilityLabChicago, Illinois, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06390930